The table below shows Arcutis Biotherapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$2.24M
-$30.38M
-$31.60M
-$80.34M
-$56.98M
-$46.20M
Capital expenditure
$0.00
$608.00K
$0.00
$82.00K
$124.00K
$554.00K
Investing cash flow
-$11.33M
$11.75M
-$28.70M
$107.75M
$15.30M
$62.00M
Dividends paid
-
-
-
-
ARQT operating cash flow (10-K history)
Arcutis Biotherapeutics, Inc. reported operating cash flow of -$5.63M for fiscal year 2025. That is up 95.0% from -$112.16M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$14.09M (FY 2018) to -$5.63M. Figures come from the company's audited annual reports as filed with the SEC.